2013 Research and Hope Award bios

June 27, 2013 1:09PM

Children’s National Medical Center Vaccine Program, under the guidance of Linda Yu-Sing Fu, MD, MSc

The Children’s National Medical Center Vaccine Program is led by Dr. Linda Yu-Sing Fu.  Dr. Fu is a general pediatrician at Children’s National Medical Center and an Associate Professor of Pediatrics at the George Washington University School of Medicine and Health Sciences. Dr. Fu’s research and advocacy interests focus on reducing barriers to childhood immunizations. She is Principal Investigator of a multi-center behavioral trial comparing the effectiveness of knowledge diffusion strategies for enhancing immunization delivery among a national sample of pediatricians. Dr. Fu also studies the psychosocial reasons for parental vaccine refusal and she recently received funding from the National Institute of Child Health and Human Development at the National Institutes of Health via the K23 mechanism to examine the influences of social networks on normative values regarding HPV vaccination acceptance among parents of early adolescents.

Dr. Fu received a ScB degree from Brown University (1996), MD from the University of California, San Diego (2000), and M.S. in Clinical Research from Tufts University (2005). She completed her pediatric residency training and a clinic research fellowship at Tufts Medical Center.

Award Rationale:

The Children’s National Medical Center Vaccine Program, under the guidance of Dr. Fu, is receiving the 2013 PhRMA Research & Hope Award for Patient and Community Health for its efforts to increase awareness of the importance of childhood immunization and raise the quality of immunization delivery to an at-risk population in the District of Columbia.  These efforts have ensured that a generation of children in our region is protected from a wide range of preventable diseases. Additionally, ongoing work at the Children’s Research Institute and through the Goldberg Center for Community Pediatric Health exemplifies the continuum of scientific study, clinical practice and stakeholder engagement that PhRMA strives to highlight through the Research & Hope Awards.